Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C67 - Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography

Sunday 04/23/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Ruple S. Laughlin, MD, FAAN
Neuromuscular and Clinical Neurophysiology (EMG)
Through this case-based session, participants should be able to demonstrate how to approach a neuromuscular patient electrodiagnostically and utilize nerve conduction studies and needle examination to: evaluate a weak patient to discern myopathy, neuromuscular junction, or motor neuron disorders; distinguish characteristics of peripheral neuropathy; and elucidate EDX findings in mononeuropathies and radiculopathies. The program will build upon electrodiagnostic knowledge acquired in Clinical EMG I.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM EST Introduction Introduction
Ruple S. Laughlin, MD, FAAN
03:35 PM - 04:05 PM EST Speaker EDX Case-Based Approach to Weakness
Ruple S. Laughlin, MD, FAAN
04:05 PM - 04:45 PM EST Speaker Peripheral Neuropathy: Electrodiagnostic Cases
Kelly G. Gwathmey, MD
04:45 PM - 05:20 PM EST Speaker EDX Cases: Plexopathies and Radiculopathies- How EDX Can Help
Devon I. Rubin, MD, FAAN
05:20 PM - 05:30 PM EST Discussion Questions and Answers
Devon I. Rubin, MD, FAAN, Ruple S. Laughlin, MD, FAAN, Kelly G. Gwathmey, MD
Faculty Disclosures
Ruple S. Laughlin, MD, FAAN Dr. Laughlin has nothing to disclose.
Devon I. Rubin, MD, FAAN Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care.
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.